BeyondSpring (BeyondSpring) Other Gross PPE : $6.25 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring Other Gross PPE?

BeyondSpring's Other Gross PPE for the quarter that ended in Dec. 2023 was $6.25 Mil.

BeyondSpring's quarterly Other Gross PPE declined from Dec. 2022 ($7.26 Mil) to Jun. 2023 ($6.75 Mil) and declined from Jun. 2023 ($6.75 Mil) to Dec. 2023 ($6.25 Mil).

BeyondSpring's annual Other Gross PPE increased from Dec. 2021 ($3.27 Mil) to Dec. 2022 ($7.26 Mil) but then declined from Dec. 2022 ($7.26 Mil) to Dec. 2023 ($6.25 Mil).

BeyondSpring Other Gross PPE Historical Data

The historical data trend for BeyondSpring's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring Other Gross PPE Chart

BeyondSpring Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

2.76

2.41

3.27

7.26

6.25

BeyondSpring Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Gross PPE	Get a 7-Day Free Trial															3.27	7.92	7.26	6.75	6.25

BeyondSpring Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

BeyondSpring (BeyondSpring) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Liberty Street, 39th Floor, New York, NY, USA, 10005

Website

https://www.beyondspringpharma.com

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.